Geode Capital Management’s Cryo-Cell International CCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$148K Buy
46,273
+2,657
+6% +$9.46K ﹤0.01% 4008
2026
Q1
$155K Sell
43,616
-9,553
-18% -$31.8K ﹤0.01% 4006
2025
Q4
$183K Sell
53,169
-247
-0.5% -$1.03K ﹤0.01% 3935
2025
Q3
$248K Buy
53,416
+7,585
+17% +$36K ﹤0.01% 3855
2025
Q2
$238K Buy
45,831
+601
+1% +$3.17K ﹤0.01% 3819
2025
Q1
$288K Buy
45,230
+5,370
+13% +$39K ﹤0.01% 3735
2024
Q4
$295K Hold
39,860
﹤0.01% 3769
2024
Q3
$254K Buy
39,860
+16,203
+68% +$112K ﹤0.01% 3825
2024
Q2
$180K Buy
23,657
+2,229
+10% +$18.4K ﹤0.01% 3952
2024
Q1
$160K Buy
21,428
+476
+2% +$2.69K ﹤0.01% 4008
2023
Q4
$121K Hold
20,952
﹤0.01% 4123
2023
Q3
$110K Buy
20,952
+1,871
+10% +$10.9K ﹤0.01% 4216
2023
Q2
$116K Hold
19,081
﹤0.01% 4278
2023
Q1
$57.6K Hold
19,081
﹤0.01% 4486
2022
Q4
$80K Sell
19,081
-77
-0.4% -$369 ﹤0.01% 4470
2022
Q3
$116K Buy
+19,158
New +$118K ﹤0.01% 4505

Other funds holding CCEL

Geode Capital Management's CCEL Position: Q2 2026 in Review

Geode Capital Management increased its Cryo-Cell International (CCEL) stake by 6.1% in Q2 2026, buying an estimated $9.46K and bringing the position to 46,273 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #4008.

Geode Capital Management first reported a position in CCEL in Q3 2022 and has held it in 16 quarters since. The position peaked at $295K in Q4 2024. 12 funds tracked by Wall St. Rank hold CCEL as of Q2 2026.

  • Geode Capital Management held 46,273 shares of Cryo-Cell International worth $148K as of Q2 2026.
  • Geode Capital Management bought 2,657 Cryo-Cell International shares in Q2 2026, an estimated $9.46K.
  • Cryo-Cell International made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4008 holding.
  • Geode Capital Management first reported a position in Cryo-Cell International in Q3 2022 and has held it in 16 quarters since.
  • Geode Capital Management's Cryo-Cell International position peaked at $295K in Q4 2024.
  • 12 funds tracked by Wall St. Rank held Cryo-Cell International as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.